When it comes to shares of Tempus AI (NASDAQ: TEM), many may feel like they're standing on a dock watching the stock sail off ...

Former House Speaker Nancy Pelosi said back in 2022 the Senate would soon vote on a bill banning members of Congress from trading individual stocks. More than two years later, Pelosi is no longer ...

Tempus AI, Inc. , a leader in artificial intelligence and precision medicine, today announced they will report financial results for the first quarter of 2025 on Tuesday, May 6, 2025. The company will ...

Illumina Inc. and Tempus AI, Inc., a technology company leading the adoption of AI to advance precision medicine and patient care, announced a collaboration to accelerate clinical adoption of ...

Learn more› By Nancy Redd We’re testing Costco Optical, which now offers single-vision prescription eyeglasses available to order completely online (with a virtual try-on option) and free in ...

Tempus AI has launched an advisory board of oncology experts to provide guidance and strategic advice to the Chicago-based company on research, product development and clinical use of its AI ...

CHICAGO, April 18, 2025--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the launch ...

Tempus Unveils Advisory Board Featuring Leading Physicians From Across the U.S. Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and ...

Illumina and Tempus AI have partnered to drive clinical adoption of next-generation sequencing tests beyond oncology, the companies said Tuesday. The collaborators will combine Illumina’s artificial ...

Toro keeps innovating irrigation management with the launch of the Tempus Decoder System, the world’s first Wi-Fi-enabled decoder solution. Developed to provide stadium managers and grounds teams with ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The Tempus 2 is the second iteration of Saucony’s niche, support-meets-speed offering. True to its name, it’s a shoe that (on paper at least) is as much geared up for tempo sessions and ‘go ...